Options Brief: Auxilium Pharmaceuticals

Shares of Auxilium Pharmaceuticals AUXL are lower on the session by 6.05%, trading at $15.05. Overall call volume is now running at 15.32x the daily average, with 3% of all calls traded being purchases on the offer. 2,650 contracts have traded on the session so far. Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic surgeons who focus on the hand, and rheumatologists.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: OptionsHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!